+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proteomics - Global Strategic Business Report

  • PDF Icon

    Report

  • 577 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 347938

Global Proteomics Market to Reach $65.3 Billion by 2030

The global market for Proteomics estimated at US$30.2 Billion in the year 2022, is projected to reach a revised size of US$65.3 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 10% CAGR and reach US$48.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11% CAGR for the next 8-year period.

The U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 12.8% CAGR

The Proteomics market in the U.S. is estimated at US$11.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Select Competitors (Total 178 Featured)

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Proteomics Market

What is the estimated value of the Proteomics Market?

The Proteomics Market was estimated to be valued at $30.2 Billion in 2022.

What is the growth rate of the Proteomics Market?

The growth rate of the Proteomics Market is 10.1%, with an estimated value of $65.3 Billion by 2030.

What is the forecasted size of the Proteomics Market?

The Proteomics Market is estimated to be worth $65.3 Billion by 2030.

Who are the key companies in the Proteomics Market?

Key companies in the Proteomics Market include Active Motif, Inc., 20/20 Genesystems, Inc., BG Medicine, Inc., BGI, Shenzhen, Biodesix, Inc., Abbiotec LLC, BioChain Institute, Inc., Arbor Vita Corporation and Biomosaics, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • 2020: A Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 on Laboratory Equipment and Supplies Market: A General Review
  • Proteomics Emerges as an Important Research Tool in Battle against COVID-19
  • Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics
  • Gaining Insights into COVID-19 & Drug Discovery with Proteomics
  • Proteomics to Enable Potent Antiviral Agents & Better Vaccines against COVID-19
  • Proteomics Labs Explore COVID-19 Therapeutic Options, Dx Development
  • Proteomics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Proteins, Proteome and Proteomics: A Prelude
  • Genesis of Proteomics
  • Important Milestones
  • An Insight into Proteomics Data Type and their Characteristics / Features
  • Proteomics and Genomics: A Comparison
  • Applications of Proteomics
  • Outlook
  • Proteomics at the Fore with Latest Advances
  • Regional Analysis
  • Key Challenges to Address
  • Sparse and Difficult to Measure Data
  • Democratizing Proteomics
  • Absence of High-Profile Projects for Stimulating Interest
  • Creating Novel Experimental Design
  • Lack of Commercialization of High Throughput Impacts
  • Lack of Necessary Technical Skillset
  • Competition
  • Recent Market Activity
  • World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Proteomics Profiling to Expedite Drug Discovery
  • Other Applications of Proteomics in Drug Discovery
  • New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
  • Diseases as a Major Cause of Deaths Worldwide Brings to Fore the Growing Importance of New Breakthroughs in Proteomics-Based Technologies: Top Global Causes of Death (In Millions) by Type of Disease for the Years 2000 and 2019
  • Global Drug Discovery Market by Segment: 2020
  • Growing Interest in Personalized Medicine to Drive Market Growth
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • Oncology: A Key Focus Area for Proteomics
  • Global Breakdown of Total Number of Cancer Cases by Type: 2020
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Proteomic Approaches Gain Prominence in Cancer Drug Discovery
  • Proteomics Technologies Used in Cancer Drug Discovery and Development
  • Role of Proteomics in Oncology Biomarker Discovery
  • List of FDA-approved Protein Biomarkers for Cancer
  • Advancements in Proteomics Bring Biomarkers into Limelight
  • Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers
  • Affinity-Reagent-Array-Based Techniques
  • Affinity-and-Antibody-Based MS Techniques
  • CE-MS Technology: An Emerging Technology for Discovery of Biomarkers
  • Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals
  • Protein Microarray Formats
  • New Technologies Expand Application of Proteomics
  • DIA Technique for Protein Discovery
  • AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
  • Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
  • Map of COVID-19 and Human Protein Interactions Reveals Drug Targets
  • Single-Cell Proteomics Offers a Better Understanding of Cellular Identity
  • Metalloproteomics: A Rapidly Evolving Field
  • Post-translational Modification of Proteins Increases Functional Diversity of Proteome
  • Pharmacoproteomics Holds Significant Prospects in Precision Medicine
  • Increasing Prominence of Nanoproteomics Widens Opportunities
  • Global Proteomics Sample Preparation Market
  • Challenges Faced
  • Management of Data in Proteomics Research Poses a Big challenge
  • Role of Contract Research Organizations to Increase in Proteomics
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Proteomics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 22: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 43: China 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 46: China 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 58: France 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 61: France 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2014, 2023 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2014, 2023 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • AUSTRALIA
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • MIDDLE EAST
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • AFRICA
  • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte